Search Results1-14 of  14

  • KASAI Chieko ID: 9000000864049

    Pharmacological Research Laboratory, Yamanouchi Seiyaku Co.,Ltd. (1998 from CiNii)

    Articles in CiNii:1

    • Age-Related Weakening of Baroreflex-Mediated Sympathetic Activity in Spontaneously Hypertensive Rats in Response to Blood Pressure Reduction (1998)
  • KASAI Chieko ID: 9000003087948

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2005 from CiNii)

    Articles in CiNii:4

    • QT PRODACT : A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles (2005)
    • QT PRODACT : Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles (2005)
    • QT PRODACT : Comparison of Non-clinical Studies for Drug-Induced Delay in Ventricular Repolarization and Their Role in Safety Evaluation in Humans (2005)
  • KASAI Chieko ID: 9000003131693

    Japan Pharmaceutical Manufacturers Association (JPMA) QT PRODACT (2004 from CiNii)

    Articles in CiNii:1

    • P8-19 QT Interval Prolongation : Project for Database Construction, 13) Species-Difference in Dose-Response Relationship of Drug-Induced QT Interval Prolongation(CIRCULATORY SYSTEM-2/ACTIVE OXYGEN)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting) (2004)
  • KASAI Chieko ID: 9000005838501

    Drug Safety Research Labs. Astellas Pharma Inc. (2005 from CiNii)

    Articles in CiNii:1

    • The screening test to evaluate QT prolongation (2005)
  • KASAI Chieko ID: 9000283729412

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2012 from CiNii)

    Articles in CiNii:1

    • Drug development and safety pharmacology study (2012)
  • KASAI Chieko ID: 9000345266864

    Astellas Pharma Inc.|Japan iPS Cardiac Safety Assessment (JiCSA)|Japanese Safety Pharmacology Society (JSPS) (2016 from CiNii)

    Articles in CiNii:1

    • Development of torsadogenic risk classification method using human induced pluripotent stem cell-derived cardiomyocytes and multi-electrode array system (2016)
  • KASAI Chieko ID: 9000345267082

    Japan iPS Cardiac Safety Assessment (JiCSA)|Japanese Safety Pharmacology Society|Astellas Pharma Inc. (2016 from CiNii)

    Articles in CiNii:1

    • Pharmacological characterization of human iPS cell-derived cardiomyocytes for assessing drug-induced, reverse use-dependent prolongation of field potential duration and pro-arrhythmic potential (2016)
  • KASAI Chieko ID: 9000345267966

    Drug Safety Research Labs., Astellas Pharma Inc. (2016 from CiNii)

    Articles in CiNii:1

    • Clinical proarrhythmic risk assessment from the safety pharmacology and non-clinical studies (2016)
  • KASAI Chieko ID: 9000347139173

    Drug Discovery of Toxicology, Drug Safety Research Laboratory, Astellas Pharma Inc. (2014 from CiNii)

    Articles in CiNii:1

    • Assessment of QT-interval prolongation and effect of the handling at safety pharmacology studies in the minipig (2014)
  • Kasai Chieko ID: 9000004530722

    Dept. Brewing and Fermentation. Tokyo Univ. of Agric (1996 from CiNii)

    Articles in CiNii:1

    • Extraction of glycoprotein from yeast cell wall (1996)
  • Kasai Chieko ID: 9000252929873

    Pharmacological Research Laboratory, Yamanouchi Seiyaku Co., Ltd. (1998 from CiNii)

    Articles in CiNii:1

    • Age-Related Weakening of Baroreflex-Mediated Sympathetic Activity in Spontaneously Hypertensive Rats in Response to Blood Pressure Reduction. (1998)
  • Kasai Chieko ID: 9000391992418

    Safety Evaluation Forum|Astellas Pharma Inc. (2009 from CiNii)

    Articles in CiNii:1

    • Update on know-how in safety pharmacology (2009)
  • Kasai Chieko ID: 9000391999909

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2007 from CiNii)

    Articles in CiNii:1

    • The effect of propylene glycol on cardiovascular system in dogs (2007)
  • Kasai Chieko ID: 9000391999923

    Drug Safety Research Laboratories, Astellas Pharma Inc. (2007 from CiNii)

    Articles in CiNii:1

    • Evaluation of the drug's effects on cardiovascular system using telemetered ferrets (2007)
Page Top